
    
      A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Non-inferiority, Phase
      III Study to Investigate the Efficacy (Immunogenicity) and Safety of GC3106 (quadrivalent
      cell-culture based influenza vaccine) after Intramuscular Administration in Healthy Subjects.
    
  